Effects Of Static Magnetic Field Exposure Research Articles

Effects of Static Magnetic Field (SMF) Exposure on Coronary Heart Disease (CHD) Risk Indicators

Dyslipidemia is a condition of abnormalities in blood lipids, such as increased LDL and decreased HDL. Exposure to intracellular static magnetic fields (SMFs) can affect membranes to modulate the number of Ca2+ ions, which can affect cell biological effects. Increasing the number of Ca2+ ions will affect the expression of genes that help reduce LDL levels as an indicator of CHD. This study aims to see whether the influence of SMFs can affect calcium levels, lipid profiles, SREBP-2 protein excretion, and LDLR gene expression, which affects the process of breaking down cholesterol. We used obese C57BL/6J male mice divided into standard and HFD feed groups. The HFD feed group was split into Obes0, Obes2, Obes7, Obes14, and Obes21 groups based on the day of exposure. The exposure was carried out with an intensity of Bmax = 2 mT for 1 h daily. After exposure to SMFs, there were changes in blood cholesterol and LDL levels, which tended to decrease in the Obes2 and Obes7 groups and increase in the Obes14 and Obes21 groups. In addition, the exposed group tended to have an increase in the expression of the LDLR gene, SREBP-2 protein, and calcium ion compared to the control. Although it managed to increase after exposure on days 14 and 21, there was a decrease in the expression of the LDLR gene and SREBP-2 protein; hence, the effect of SMF exposure can reduce the risk of CHD. However, research still needs to be done regarding the effective duration of exposure.

Influence of local exposure to static magnetic field on pain perception and bone turnover of osteoporotic patients with vertebral deformity – a randomized controlled trial

Purpose: Static magnetic field (SMF) could improve pain sensation and bone turnover. In a single-center randomized double-blind placebo-controlled study we investigated the effects of SMF exposure on subjective pain and bone turnover.Materials and methods: Postmenopausal osteoporotic women (aged 50–70 years) with bone deformity and back pain were randomized to 10 weekly visits of 30-min SMF (n = 6) or treatment with non-magnetized pads (n = 5) on the back. Primary and secondary outcomes were changes in pain sensation on a visual analogue scale (VAS) during each visit and over 10 weeks, respectively. Tertiary outcomes were changes in osteocalcin and β-crosslaps. SMF was inhomogeneous with 192 millitesla peak-to-peak value by 19 tesla/meter gradient of the magnetic flux density at 3 mm.Results: Participants randomized to sham had higher VAS at baseline (mean difference: 2.8, 95% confidence interval (CI) 0.47–5.2 cm). Both SMF and sham similarly reduced short term pain (sham-SMF: 0.59, 95% CI − 0.31–1.49 cm, p = 0.195). VAS did not change in SMF, while it decreased in the sham group (between-group difference 0.27, 95% CI 0.04–0.50 cm/visit). Bone turnover markers remained stable.Conclusions: SMF as used in this investigation is not recommended for pain relief in postmenopausal women with vertebral deformity. The finding on long-term pain relief may relate to unbalanced randomization.

Biological effects of 6 mT static magnetic fields: A comparative study in different cell types

The present work was a comparative study of the bio-effects induced by exposure to 6 mT static magnetic field (MF) on several primary cultures and cell lines. Particular attention was dedicated to apoptosis. Cell viability, proliferation, intracellular Ca(2+) concentration and morphology were also examined. Primary cultures of human lymphocytes, mice thymocytes and cultures of 3DO, U937, HeLa, HepG2 and FRTL-5 cells were grown in the presence of 6 mT static MF and different apoptosis-inducing agents (cycloheximide, H(2)O(2), puromycin, heat shock, etoposide). Biological effects of static MF exposure were found in all the different cells examined. They were cell type-dependent but apoptotic inducer-independent. A common effect of the exposure to static MF was the promotion of apoptosis and mitosis, but not of necrosis or modifications of the cell shape. Increase of the intracellular levels of Ca(2+) ions were also observed. When pro-apoptotic drugs were combined with static MF, the majority of cell types rescued from apoptosis. To the contrary, apoptosis of 3DO cells was significantly increased under simultaneous exposure to static MF and incubation with pro-apoptotic drugs. From these data we conclude that 6 mT static MF exposure interfered with apoptosis in a cell type- and exposure time-dependent manner, while the effects of static MF exposure on the apoptotic program were independent of the drugs used.